Elekta expands in Poland through acquisition

STOCKHOLM, March 17, 2015 – Elekta (EKTA-B.ST) has today completed its acquisition of Polish distributor, RTA, as announced August 25, 2014 . This deal will allow Elekta to leverage RTA’s existing relationships in order to strengthen Elekta’s position in Poland’s private and public health care sectors.

Ian Alexander, Executive Vice President of Elekta's Region Europe, Africa, Latin America and Middle East, says: “The radiation therapy market is growing steadily as both private and public care providers strive to meet the need to deliver improved treatments. Bringing RTA into the Elekta family is a natural progression that will help meet this need and will benefit Polish cancer centers and, ultimately, their patients.

“Elekta’s strengthened position in Poland will also enable it to increase its presence in state-run and teaching hospitals,” he adds.

As previously stated, the acquisition of RTA is expected to add 0.3 percent to Elekta’s revenues on an annual basis and is expected to be EPS accretive on an annual basis.

With this finalization, RTA will change its name to Elekta and become a wholly-owned subsidiary.

# # #

For further information, please contact:
Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

Gert van Santen, Group Vice President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on March 17, 2015.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com .

Tags:

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links